The Society of Gynecologic Oncologists (SGO) will host its 41st Annual Meeting on Women's Cancer March 14-17, 2010 at the Moscone West Convention Center in San Francisco, California. This year's meeting will feature more than 434 scientific presentations in addition to lectures, workshops, symposia and postgraduate courses that focus on emerging science, clinical trials and treatment advances for physicians and health care professionals in the field of gynecologic oncology. This year's meeting attracted 839 research and clinical trial abstracts submitted from all over the world the most submitted since the Annual Meeting's inception in 1969.
A fictional television drama may be more effective in persuading young women to use birth control than a news-format program on the same issue, according to a new study. Researchers found that college-age women who viewed a televised drama about a teen pregnancy felt more vulnerable two weeks after watching the show, and this led to more support for using birth control. However, those who watched a news program detailing the difficulties caused by teen pregnancies were unmoved, and had no change in their intentions to use birth control. The results show the power that narratives like TV shows can have in influencing people, said Emily Moyer-GusÃ, co-author of the study and assistant professor of communication at Ohio State University.
A new study published in BJOG: An International Journal of Obstetrics and Gynaecology examines how the swine flu virus, Influenza A H1N1 (2009), affects pregnant women. Clinicians at the KK Women's and Children's Hospital in Singapore treated 211 confirmed cases of pregnant women with swine flu between 26 May 2009 and 14 September 2009. These were women who had fever and/or acute respiratory illness at presentation and a positive diagnosis of having swine flu through a throat swab. Most of these patients reported having fever at home but only 62.2% had a fever when they arrived at hospital. Cough was the most prevalent symptom, occurring in 90.
Sen. Scott Brown, R-Mass., won an upset election last month that has reshaped the health debate and that new dynamic could be a boon for lobbying firms, The Philadelphia Inquirer's Law Review columnist writes. "The thousands of lobbyists on and off Capitol Hill who labor on behalf of health-industry clients can now count on at least a few more monthly retainers. ... Nothing stimulates the flow of lobbying dollars like uncertainty on Capitol Hill." One Philadelphia legal firm, Cozen O'Connor, which is known for its insurance-defense practice, is chasing the health debate's new opportunities. "Like many of its peer law firms in Philadelphia and around the country, it has been hustling to bolster its government-relations (lobbying) practice in Washington" (Mondics, 2/9).
A mutation in a single gene can cause endometrial cancer that is responsive to a specific drug therapy, researchers at UT Southwestern Medical Center have found in an animal study. The finding suggests that eventually it might be possible to screen women with endometrial cancer to see if they have that mutation and use the drug as targeted therapy, the researchers said. "Our data suggest that deficiency of this gene can indicate both how aggressive an endometrial tumor will be and how well it might respond to a specific class of drugs, " said Dr. Diego Castrillon, assistant professor of pathology at UT Southwestern and senior author of the paper, which appears in the March/April issue of Disease Models and Mechanisms.
Researchers from Boston University's Slone Epidemiology Center have found a direct link between neighborhood socioeconomic status and risk for type 2 diabetes in African American women. The study, which appears in the online American Journal of Epidemiology, is the first prospective study to examine the relationship between neighborhood socioeconomic status and incidence of type 2 diabetes in a large, geographically diverse cohort of African-American women. Type 2 diabetes is estimated to affect 20.6 million people in the United States and has particularly impacted African-American women, who are twice as likely to have the disease as non-Hispanic whites.